hayashi rice
Selected indexed studies
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. (N Engl J Med, 2020) [PMID:33264825]
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. (N Engl J Med, 2021) [PMID:34449181]
- The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice. (Nat Commun, 2020) [PMID:33177522]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Mapping the human genetic architecture of COVID-19. (2021) pubmed
- SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. (2021) pubmed
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. (2021) pubmed
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. (2022) pubmed
- Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis. (2022) pubmed
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. (2020) pubmed
- The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice. (2020) pubmed
- Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trial. (2021) pubmed
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (2013) pubmed
- Cell-type specific, inducible and acute degradation of targeted protein in mice by two degron systems. (2024) pubmed